{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:11:48Z","timestamp":1779372708304,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04921-4","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T18:23:25Z","timestamp":1764872605000},"page":"1963-1970","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the efficacy and safety of different doses of daily paroxetine in patients with lifelong premature ejaculation: a prospective randomized crossover study"],"prefix":"10.1007","volume":"58","author":[{"given":"Sameh Fayek","family":"GamalEl Din","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Raef","family":"Sadek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Yousry","family":"Elamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Ahmed","family":"Ateya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham Hanafy","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Fawzy","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"12","key":"4921_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrurol.2015.252","volume":"11","author":"TR Saitz","year":"2015","unstructured":"Saitz TR, Serefoglu EC (2015) Advances in understanding and treating premature ejaculation. Nat Rev Urol 11(12):629\u2013640. https:\/\/doi.org\/10.1038\/nrurol.2015.252","journal-title":"Nat Rev Urol"},{"issue":"6","key":"4921_CR2","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1111\/j.1743-6109.2008.00825.x","volume":"5","author":"RC Rosen","year":"2008","unstructured":"Rosen RC, Althof S (2008) Impact of premature ejaculation: the psychological, quality of life, and sexual relationship consequences. J Sex Med 5(6):1296\u20131307. https:\/\/doi.org\/10.1111\/j.1743-6109.2008.00825.x","journal-title":"J Sex Med"},{"issue":"2","key":"4921_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/sm2.27","volume":"2","author":"EC Serefoglu","year":"2014","unstructured":"Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, Becher EF, Dean J, Giuliano F, Hellstrom WJG, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, Torres LO (2014) An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second international society for sexual medicine ad hoc committee for the definition of premature ejaculation. Sex Med 2(2):41\u201359. https:\/\/doi.org\/10.1002\/sm2.27","journal-title":"Sex Med"},{"issue":"1","key":"4921_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00041444-199800810-00007","volume":"8","author":"MD Waldinger","year":"1998","unstructured":"Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B (1998) Familial occurrence of primary premature ejaculation. Psychiatr Genet 8(1):37\u201340. https:\/\/doi.org\/10.1097\/00041444-199800810-00007","journal-title":"Psychiatr Genet"},{"issue":"1","key":"4921_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1743-6109.2004.10109.x","volume":"1","author":"CG McMahon","year":"2004","unstructured":"McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin ZC (2004) Disorders of orgasm and ejaculation in men. J Sex Med 1(1):58\u201365. https:\/\/doi.org\/10.1111\/j.1743-6109.2004.10109.x","journal-title":"J Sex Med"},{"issue":"10","key":"4921_CR6","doi-asserted-by":"publisher","DOI":"10.1111\/and.14549","volume":"54","author":"SF GamalEl Din","year":"2022","unstructured":"GamalEl Din SF, Motawi AT, Rashed LA, Elghobary H, Saad HM, Ismail MM, Abdel-latif HF (2022) Study of the role of microRNAs 16 and 135a in patients with lifelong premature ejaculation receiving fluoxetine daily for 3 months: a prospective case control study. Andrologia 54(10):e14549. https:\/\/doi.org\/10.1111\/and.14549","journal-title":"Andrologia"},{"key":"4921_CR7","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.sxmr.2021.11.003","volume":"10","author":"DL Rowland","year":"2022","unstructured":"Rowland DL, Althof SE, McMahon CG (2022) The unfinished business of defining premature ejaculation: the need for targeted research. Sex Med Rev 10:323\u2013340","journal-title":"Sex Med Rev"},{"key":"4921_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.urology.2016.02.018","volume":"93","author":"SE Althof","year":"2016","unstructured":"Althof SE, McMahon CG (2016) Contemporary management of disorders of male orgasm and ejaculation. Urology 93:9\u201321. https:\/\/doi.org\/10.1016\/j.urology.2016.02.018","journal-title":"Urology"},{"issue":"6","key":"4921_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1124\/dmd.105.004077","volume":"33","author":"K Venkatakrishnan","year":"2005","unstructured":"Venkatakrishnan K, Obach RS (2005) In vitro-in vivo extrapolation of CYP2D6 inactivation by paroxetine: prediction of nonstationary pharmacokinetics and drug interaction magnitude. Drug Metab Dispos 33(6):845\u2013852. https:\/\/doi.org\/10.1124\/dmd.105.004077","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"4921_CR10","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/FPC.0000000000000228","volume":"26","author":"M Nishimura","year":"2016","unstructured":"Nishimura M, Ueda M, Saruwatari J, Nakashima H, Ogusu N, Aoki A, Tsuchimine S, Matsuda K, Iwashita K, Ono T, Oniki K, Shimoda K, Yasui-Furukori N (2016) Influence of the cytochrome P450 2D6 *10\/*10 genotype on the pharmacokinetics of paroxetine in Japanese patients with major depressive disorder: a population pharmacokinetic analysis. Pharmacogenet Genom 26(9):403\u2013413. https:\/\/doi.org\/10.1097\/FPC.0000000000000228","journal-title":"Pharmacogenet Genom"},{"issue":"2","key":"4921_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ijir.2014.37","volume":"27","author":"P Jern","year":"2015","unstructured":"Jern P, Johansson A, Piha J, Westberg L, Santtila P (2015) Antidepressant treatment of premature ejaculation: discontinuation rates and prevalence of side effects for dapoxetine and paroxetine in a naturalistic setting. Int J Impot Res 27(2):75\u201380. https:\/\/doi.org\/10.1038\/ijir.2014.37","journal-title":"Int J Impot Res"},{"issue":"5","key":"4921_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.4103\/1008-682X.128467","volume":"16","author":"A Simsek","year":"2014","unstructured":"Simsek A, Kirecci SL, Kucuktopcu O, Ozgor F, Akbulut MF, Sarilar O et al (2014) Comparison of paroxetine and dapoxetine, a novel selective serotonin reuptake inhibitor in the treatment of premature ejaculation. Asian J Androl 16(5):725\u2013727. https:\/\/doi.org\/10.4103\/1008-682X.128467","journal-title":"Asian J Androl"},{"issue":"7","key":"4921_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/and.14425","volume":"54","author":"C Zhong","year":"2022","unstructured":"Zhong C, Li C, Geng Q, Han Q, Gao Q, Zhang J, Wang F, Guo J (2022) Reasons and treatment strategy for discontinuation of dapoxetine treatment in premature ejaculation patients in China: a retrospective observational study. Andrologia 54(7):e14425. https:\/\/doi.org\/10.1111\/and.14425","journal-title":"Andrologia"},{"issue":"1","key":"4921_CR14","doi-asserted-by":"publisher","DOI":"10.5812\/numonthly.32286","volume":"8","author":"E Moudi","year":"2016","unstructured":"Moudi E, Kasaeeyan AA (2016) Comparison between Tadalafil plus paroxetine and paroxetine alone in the treatment of premature ejaculation. Nephrourol Mon 8(1):e32286. https:\/\/doi.org\/10.5812\/numonthly.32286","journal-title":"Nephrourol Mon"},{"issue":"20","key":"4921_CR15","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191\u20132194. https:\/\/doi.org\/10.1001\/jama.2013.281053","journal-title":"JAMA"},{"issue":"5","key":"4921_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/sj.ijir.3901248","volume":"16","author":"R Shamloul","year":"2004","unstructured":"Shamloul R, Ghanem H, Abou-zeid A (2004) Validity of the Arabic version of the sexual health inventory for men among Egyptians. Int J Impot Res 16(5):452\u2013455. https:\/\/doi.org\/10.1038\/sj.ijir.3901248","journal-title":"Int J Impot Res"},{"issue":"8","key":"4921_CR17","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1111\/j.1743-6109.2010.01789.x","volume":"7","author":"M Alghobary","year":"2010","unstructured":"Alghobary M, El-Bayoumy Y, Mostafa Y, Mahmoud el-HM AM (2010) Evaluation of tramadol on demand vs. daily paroxetine as a long-term treatment of lifelong premature ejaculation. J Sex Med 7(8):2860\u20132867. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.01789.x","journal-title":"J Sex Med"},{"issue":"2","key":"4921_CR18","doi-asserted-by":"publisher","first-page":"S224","DOI":"10.1016\/j.jsxm.2016.03.319","volume":"13","author":"M Hassan","year":"2016","unstructured":"Hassan M, Hassan MMM (2016) P-05-019 comparison of paroxetine and dapoxetine regarding intra vaginal ejaculatory latency time and sexual intercourse frequency in patients with lifelong premature ejaculation. J Sex Med 13(2):S224\u2013S224. https:\/\/doi.org\/10.1016\/j.jsxm.2016.03.319","journal-title":"J Sex Med"},{"key":"4921_CR19","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/j.1743-6109.2006.00213.x","volume":"4","author":"M Arafa","year":"2007","unstructured":"Arafa M, Shamloul R (2007) Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE). J Sex Med 4:1750\u20131756. https:\/\/doi.org\/10.1111\/j.1743-6109.2006.00213.x","journal-title":"J Sex Med"},{"key":"4921_CR20","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1743-6109.2007.00749.x","volume":"3","author":"L Abraham","year":"2008","unstructured":"Abraham L, Symonds T, Morris MF (2008) Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction. J Sex Med 3:595\u2013601. https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00749.x","journal-title":"J Sex Med"},{"issue":"3","key":"4921_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ijir.2016.7","volume":"28","author":"L Cai","year":"2016","unstructured":"Cai L, Wen Y, Jiang M, Zeng M, Zhang B (2016) Premature ejaculation results from partners\u2019 mismatch: development and validation of index of intra-vaginal ejaculation latency time. Int J Impot Res 28(3):101\u2013105. https:\/\/doi.org\/10.1038\/ijir.2016.7","journal-title":"Int J Impot Res"},{"issue":"4","key":"4921_CR22","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1046\/j.1464-410x.1997.00102.x","volume":"79","author":"MD Waldinger","year":"1997","unstructured":"Waldinger MD, Hengeveld MW, Zwinderman AH (1997) Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol 79(4):592\u2013595. https:\/\/doi.org\/10.1046\/j.1464-410x.1997.00102.x","journal-title":"Br J Urol"},{"key":"4921_CR23","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds) (2022) Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane. www.training.cochrane.org\/handbook"},{"issue":"1","key":"4921_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-018-0431-7","volume":"19","author":"D Zhang","year":"2019","unstructured":"Zhang D, Cheng Y, Wu K, Ma Q, Jiang J, Yan Z (2019) Paroxetine in the treatment of premature ejaculation: a systematic review and meta-analysis. BMC Urol 19(1):2. https:\/\/doi.org\/10.1186\/s12894-018-0431-7","journal-title":"BMC Urol"},{"issue":"5","key":"4921_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.WNF.0000228210.12194.46","volume":"29","author":"MR Safarinejad","year":"2006","unstructured":"Safarinejad MR (2006) Comparison of dapoxetine versus paroxetine in patients with premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Clin Neuropharmacol 29(5):243\u2013252. https:\/\/doi.org\/10.1097\/01.WNF.0000228210.12194.46","journal-title":"Clin Neuropharmacol"},{"key":"4921_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/and.12829","author":"EM Abu","year":"2018","unstructured":"Abu EM, Abdelhamed A (2018) Comparison of the clinical efficacy and safety of the on-demand use of paroxetine, dapoxetine, sildenafil and combined dapoxetine with sildenafil in treatment of patients with premature ejaculation: a randomised placebo-controlled clinical trial. Andrologia. https:\/\/doi.org\/10.1111\/and.12829","journal-title":"Andrologia"},{"issue":"5","key":"4921_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/and.14388","volume":"54","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, Yang Z, Cui Y, Zhang X, Wang Y, Zhang Y (2022) The network meta-analysis of \u201con-demand\u201d and \u201cdaily\u201d use of paroxetine in treating men with premature ejaculation from randomized controlled trials. Andrologia 54(5):e14388. https:\/\/doi.org\/10.1111\/and.14388","journal-title":"Andrologia"},{"issue":"4","key":"4921_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1442-2042.2007.01606.x","volume":"14","author":"WF Wang","year":"2007","unstructured":"Wang WF, Wang Y, Minhas S, Ralph DJ (2007) Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol 14(4):331\u2013335. https:\/\/doi.org\/10.1111\/j.1442-2042.2007.01606.x","journal-title":"Int J Urol"},{"key":"4921_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbr.2012.07.029","volume":"235","author":"S Adams","year":"2012","unstructured":"Adams S, Heckard D, Hassell J, Uphouse L (2012) Factors influencing fluoxetine-induced sexual dysfunction in female rats. Behav Brain Res 235:73\u201381","journal-title":"Behav Brain Res"},{"key":"4921_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.9740\/mhc.2016.07.191","volume":"6","author":"BS Jing","year":"2016","unstructured":"Jing BS, Straw-Wilson K (2016) Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: a narrative literature review. Ment Health Clin 6:191\u2013196","journal-title":"Ment Health Clin"},{"key":"4921_CR31","first-page":"74894","volume":"2013","author":"SK Goswami","year":"2013","unstructured":"Goswami SK, Inamdar MN, Pandre MK, Jamwal R, Dethe S (2013) Erectogenic and aphrodisiac effects of Butea frondosa Koenig ex Roxb. in rats: involvement of enzyme inhibition. Evid Complement Altern Med 2013:74894","journal-title":"Evid Complement Altern Med"},{"issue":"2","key":"4921_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/sj.ijir.3900950","volume":"15","author":"J Angulo","year":"2003","unstructured":"Angulo J, Bischoff E, Gabancho S, Cuevas P, de S\u00e1enz Tejada I (2003) Vardenafil reverses erectile dysfunction induced by paroxetine in rats. Int J Impot Res 15(2):90\u201393. https:\/\/doi.org\/10.1038\/sj.ijir.3900950","journal-title":"Int J Impot Res"},{"issue":"2","key":"4921_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2165\/00023210-199708020-00010","volume":"8","author":"RH Foster","year":"1997","unstructured":"Foster RH, Goa KL (1997) Paroxetine: a review of its pharmacology and therapeutic potential in the management of panic disorder. CNS Drugs 8(2):163\u2013188. https:\/\/doi.org\/10.2165\/00023210-199708020-00010","journal-title":"CNS Drugs"},{"issue":"18","key":"4921_CR34","first-page":"14","volume":"64","author":"CL DeVane","year":"2003","unstructured":"DeVane CL (2003) Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea. J Clin Psychiatry 64(18):14\u201319","journal-title":"J Clin Psychiatry"},{"key":"4921_CR35","unstructured":"U.S. Food and Drug Administration (2014) PAXIL CR\u00ae (PAX-il) (paroxetine hydrochloride) Controlled-Release Tablets. https:\/\/www.fda.gov\/media\/80223\/download. Accessed June 2014"},{"key":"4921_CR36","unstructured":"U.S. Food and Drug Administration (2015) Paroxetine (marketed as paxil) information. https:\/\/www.fda.gov\/drugs\/postmarket-drug-safetyinformation-patients-and-providers\/paroxetine-marketed-paxil-information. Accessed 17 July 2015"},{"key":"4921_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.491895","volume":"11","author":"B Carvalho Henriques","year":"2020","unstructured":"Carvalho Henriques B, Yang EH, Lapetina D, Carr MS, Yavorskyy V, Hague J et al (2020) How can drug metabolism and transporter genetics inform psychotropic prescribing? Front Genet 11:491895. https:\/\/doi.org\/10.3389\/fgene.2020.491895","journal-title":"Front Genet"},{"key":"4921_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.966622","volume":"13","author":"X-l Li","year":"2022","unstructured":"Li X-l, Huang S-q, Xiao T, Wang X-p, Kong W, Liu S-j et al (2022) Pharmacokinetics of immediate and sustained-release formulations of paroxetine: population pharmacokinetic approach to guide paroxetine personalized therapy in Chinese psychotic patients. Front Pharmacol 13:966622. https:\/\/doi.org\/10.3389\/fphar.2022.966622","journal-title":"Front Pharmacol"},{"issue":"8","key":"4921_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00228-004-0792-6","volume":"60","author":"K Sawamura","year":"2004","unstructured":"Sawamura K, Suzuki Y, Someya T (2004) Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine. Eur J Clin Pharmacol 60(8):553\u2013557. https:\/\/doi.org\/10.1007\/s00228-004-0792-6","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"4921_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/WNF.0000000000000058","volume":"38","author":"T Tomita","year":"2015","unstructured":"Tomita T, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S, Nakamura K, Yasui-Furukori N (2015) Effects of age on paroxetine efficacy in patients with major depressive disorder who do not exhibit an early response to treatment. Clin Neuropharmacol 38(1):6\u201310. https:\/\/doi.org\/10.1097\/WNF.0000000000000058","journal-title":"Clin Neuropharmacol"},{"key":"4921_CR41","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.eururo.2006.07.004","volume":"51","author":"H Porst","year":"2007","unstructured":"Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J (2007) The premature ejaculation prevalence and attitudes (PEPA) survey: prevalence, comorbidities, and professional help-seeking. Eur Urol 51:816\u2013823","journal-title":"Eur Urol"},{"key":"4921_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jadohealth.2012.01.008","volume":"51","author":"A Mialon","year":"2012","unstructured":"Mialon A, Berchtold A, Michaud PA, Gmel G, Suris JC (2012) Sexual dysfunctions among young men: prevalence and associated factors. J Adolesc Health 51:25\u201331","journal-title":"J Adolesc Health"},{"key":"4921_CR43","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jadohealth.2014.05.014","volume":"55","author":"C Akre","year":"2014","unstructured":"Akre C, Berchtold A, Gmel G, Suris JC (2014) The evolution of sexual dysfunction in young men aged 18\u201325 years. J Adolesc Health 55:736\u2013743","journal-title":"J Adolesc Health"},{"key":"4921_CR44","doi-asserted-by":"publisher","first-page":"537e44","DOI":"10.1001\/jama.281.6.537","volume":"281","author":"EO Laumann","year":"1999","unstructured":"Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281:537e44","journal-title":"JAMA"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04921-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04921-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:41:20Z","timestamp":1779370880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04921-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["4921"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04921-4","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the local ethical committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}